UK markets closed

Tarsus Pharmaceuticals, Inc. (TARS)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
33.87+1.58 (+4.89%)
As of 03:08PM EDT. Market open.
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts8887
Avg. Estimate-1.2-1.07-4.18-1.88
Low estimate-1.32-1.31-4.93-3.57
High estimate-0.89-0.92-3.3-0.35
Year ago EPS-0.88-1.17-4.62-4.18
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts7787
Avg. Estimate17.83M23.59M99.74M200.61M
Low estimate15.71M18.99M75M175M
High estimate20.1M26.27M113.51M239.87M
Year ago sales3.12MN/A17.45M99.74M
Sales growth (year/est)471.50%N/A471.70%101.10%
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-0.94-1.08-1.36-1.36
Actual EPS-0.88-1.17-1.28-1.31
Difference0.06-0.090.080.05
Surprise %6.40%-8.30%5.90%3.70%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-1.2-1.07-4.18-1.88
7 days ago-1.23-1.11-4.36-2.14
30 days ago-1.25-1.12-4.39-2.14
60 days ago-1.39-1.33-4.88-2.18
90 days ago-1.37-1.34-4.91-2.19
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 days2221
Up last 30 days2221
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesTARSIndustrySector(s)S&P 500
Current qtr.-36.40%N/AN/AN/A
Next qtr.8.50%N/AN/AN/A
Current year9.50%N/AN/AN/A
Next year55.00%N/AN/AN/A
Next 5 years (per annum)-20.70%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A